Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ibrance 75mg tablets (Pfizer Ltd) 21 tablet 3 x 7 tablets |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
False |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ibrance 100mg tablets (Pfizer Ltd) 21 tablet 3 x 7 tablets |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
False |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ibrance 125mg tablets (Pfizer Ltd) 21 tablet 3 x 7 tablets |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
False |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ibrance 100mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
False |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Polivy 140mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Fingolimod 500microgram capsules (A A H Pharmaceuticals Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Fingolimod 500microgram capsules (A A H Pharmaceuticals Ltd) 7 capsule |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Giapreza 2.5mg/1ml concentrate for solution for infusion vials (PAION Netherlands B.V.) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Rinvoq 30mg modified-release tablets (AbbVie Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ibrance 100mg tablets (Pfizer Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
False |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Welireg 40mg tablets (Merck Sharp & Dohme (UK) Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ultomiris 1,100mg/11ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ultomiris 300mg/3ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Livtencity 200mg tablets (Takeda UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ponvory 9mg tablets (Janssen-Cilag Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ponvory 5mg tablets (Janssen-Cilag Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Lagevrio 200mg capsules (Merck Sharp & Dohme (UK) Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Adjuvanted quadrivalent influenza vaccine (surface antigen, inactivated) suspension for injection 0.5ml pre-filled syringes (Seqirus UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Xenpozyme 20mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ultomiris 300mg/3ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ultomiris 1,100mg/11ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Sixmo 74.2mg implant (Accord Healthcare Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Retsevmo 80mg capsules (Eli Lilly and Company Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Leqvio 284mg/1.5ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Xenpozyme 20mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Sovaldi 200mg granules sachets (Gilead Sciences Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ivabradine 7.5mg tablets (Crescent Pharma Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
False |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ivabradine 5mg tablets (Crescent Pharma Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
False |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ivabradine 5mg tablets (Crescent Pharma Ltd) 56 tablet 4 x 14 tablets |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
False |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ivabradine 7.5mg tablets (Crescent Pharma Ltd) 56 tablet 4 x 14 tablets |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
False |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Harvoni 45mg/200mg granules sachets (Gilead Sciences Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Cell-based quadrivalent influenza vaccine (surface antigen, inactivated) suspension for injection 0.5ml pre-filled syringes (Seqirus UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd) 50 dose 10 x 5 dose vials |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd) 5 dose |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Rybrevant 350mg/7ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Vitrakvi 20mg/ml oral solution sugar free (Bayer Plc) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Vitrakvi 20mg/ml oral solution sugar free (Bayer Plc) 100 ml 2 x 50ml bottles |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Rybrevant 350mg/7ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Regkirona 960mg/16ml concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Regkirona 960mg/16ml concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Xeljanz 1mg/ml oral solution (Pfizer Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
False |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 56 capsule 4 x 14 capsules |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Xeljanz 1mg/ml oral solution (Pfizer Ltd) 240 ml |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
False |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Retsevmo 80mg capsules (Eli Lilly and Company Ltd) 56 capsule 4 x 14 capsules |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 84 tablet 3 x 28 tablets |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Retsevmo 80mg capsules (Eli Lilly and Company Ltd) 112 capsule 8 x 14 capsules |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Retsevmo 40mg capsules (Eli Lilly and Company Ltd) 168 capsule 8 x 21 capsules |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Jemperli 500mg/10ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Paxlovid 150mg/100mg tablets (Pfizer Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Jemperli 500mg/10ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Paxlovid 150mg/100mg tablets (Pfizer Ltd) 30 tablet 5 x (4 tablets + 2 tablets) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Ajovy 225mg/1.5ml solution for injection pre-filled pens (Teva UK Ltd) 3 pre-filled disposable injection |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Lyumjev Tempo Pen 100units/ml solution for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Lyumjev Tempo Pen 100units/ml solution for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) 5 pre-filled disposable injection |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Libmeldy 2million-10million cells/ml dispersion for infusion bags (Orchard Therapeutics (Europe) Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Xevudy 500mg/8ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Minjuvi 200mg powder for concentrate for solution for infusion vials (Incyte Biosciences UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Sovaldi 150mg granules sachets (Gilead Sciences Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Vegzelma 100mg/4ml concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Vydura 75mg oral lyophilisates (Pfizer Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Sovaldi 200mg tablets (Gilead Sciences Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Welireg 40mg tablets (Merck Sharp & Dohme (UK) Ltd) 90 tablet |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Tavneos 10mg capsules (Vifor Fresenius Medical Care Renal Pharma UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Xerava 100mg powder for concentrate for solution for infusion vials (PAION Netherlands B.V.) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Atgam 250mg/5ml concentrate for solution for infusion ampoules (Pfizer Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Giapreza 2.5mg/1ml concentrate for solution for infusion vials (PAION Netherlands B.V.) 10 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Mounjaro 2.5mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Cevenfacta 2mg (90,000units) powder and solvent for solution for injection vials (LFB Biopharmaceuticals Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Cevenfacta 1mg (45,000units) powder and solvent for solution for injection vials (LFB Biopharmaceuticals Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Hepcludex 2mg powder for solution for injection vials (Gilead Sciences Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Cevenfacta 5mg (225,000units) powder and solvent for solution for injection vials (LFB Biopharmaceuticals Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Mounjaro 5mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Cevenfacta 5mg (225,000units) powder and solvent for solution for injection vials (LFB Biopharmaceuticals Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Mounjaro 2.5mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) 4 pre-filled disposable injection |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Cevenfacta 1mg (45,000units) powder and solvent for solution for injection vials (LFB Biopharmaceuticals Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Mounjaro 5mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) 4 pre-filled disposable injection |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Hepcludex 2mg powder for solution for injection vials (Gilead Sciences Ltd) 30 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Cevenfacta 2mg (90,000units) powder and solvent for solution for injection vials (LFB Biopharmaceuticals Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Vydura 75mg oral lyophilisates (Pfizer Ltd) 8 tablet |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Vydura 75mg oral lyophilisates (Pfizer Ltd) 2 tablet |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Sovaldi 150mg granules sachets (Gilead Sciences Ltd) 28 sachet |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Tavneos 10mg capsules (Vifor Fresenius Medical Care Renal Pharma UK Ltd) 180 capsule |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Sovaldi 200mg tablets (Gilead Sciences Ltd) 28 tablet |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Sovaldi 200mg granules sachets (Gilead Sciences Ltd) 28 sachet |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Harvoni 45mg/200mg granules sachets (Gilead Sciences Ltd) 28 sachet |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Pluvicto 7,400MBq/7.5-12.5ml solution for injection vials (Advanced Accelerator Applications (UK & Ireland) Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Sondelbay 20micrograms/80microlitres solution for injection 2.4ml pre-filled pens (Accord Healthcare Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Vyepti 100mg/1ml concentrate for solution for infusion vials (Lundbeck Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Locametz 25microgram kit for radiopharmaceutical preparation (Advanced Accelerator Applications (UK & Ireland) Ltd) |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Sondelbay 20micrograms/80microlitres solution for injection 2.4ml pre-filled pens (Accord Healthcare Ltd) 3 pre-filled disposable injection |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Locametz 25microgram kit for radiopharmaceutical preparation (Advanced Accelerator Applications (UK & Ireland) Ltd) 1 kit |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|
Pluvicto 7,400MBq/7.5-12.5ml solution for injection vials (Advanced Accelerator Applications (UK & Ireland) Ltd) 1 vial |
Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator |
True |
EMA (European Medicines Agency) monitoring |
Inferred relationship |
Existential restriction modifier |
|